These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2871951)

  • 1. Effect of fenoldopam on the aldosterone response to metoclopramide in man.
    Dupont AG; Vanderniepen P; Volckaert A; Smitz J; Vansteirteghem AC; Six RO
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):203-8. PubMed ID: 2871951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1986 Jan; 21(1):53-61. PubMed ID: 2868748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and endocrine effects of fenoldopam and metoclopramide in normal man.
    Girbes AR; Smit AJ; Meijer S; Reitsma WD
    Nephron; 1990; 56(2):179-85. PubMed ID: 1978736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenoldopam: effect on aldosterone secretion.
    Dupont AG; Vanderniepen P; Volckaert A; Smitz J; Vansteirteghem AC; Six RO
    Br J Clin Pharmacol; 1986 Feb; 21(2):243-4. PubMed ID: 2869776
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
    Dupont AG; Vanderniepen P; Smitz JJ; Six RO
    Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
    Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
    J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
    Francis GS; Wilson BC; Rector TS
    Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man.
    Hughes JM; Beck TR; Rose CE; Carey RM
    J Clin Endocrinol Metab; 1988 Mar; 66(3):518-25. PubMed ID: 2895118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metoclopramide on aldosterone and regulatory factors in man.
    Gilchrist NL; Espiner EA; Nicholls MG; Donald RA
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):1-7. PubMed ID: 6086181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metoclopramide on the secretion of aldosterone and other adrenocortical steroids.
    Nagahama S; Fujimaki M; Kawabe H; Nakamura R; Saito I; Saruta T
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):287-93. PubMed ID: 6861367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
    Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients.
    Luchsinger A; Grilli M; Forte P; Morales E; Velasco M
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):509-12. PubMed ID: 8520809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
    Murphy MB; McCoy CE; Weber RR; Frederickson ED; Douglas FL; Goldberg LI
    Circulation; 1987 Dec; 76(6):1312-8. PubMed ID: 2890447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro effects of metoclopramide on aldosterone secretion in rats.
    Nagahama S; Fujimaki M; Suzuki H; Kawabe H; Saito I; Saruta T
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):589-93. PubMed ID: 6342328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
    Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
    Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoclopramide and domperidone block the antihypertensive effect of bromocriptine in hypertensive patients.
    Luchsinger A; Grilli M; Velasco M
    Am J Ther; 1998 Mar; 5(2):81-8. PubMed ID: 10099042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral fenoldopam (SKF 82526-J), a peripheral dopamine receptor agonist, on blood pressure and renal function in normal man.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1985 Jan; 19(1):21-7. PubMed ID: 2858215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
    Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
    Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.